Turning genome-wide association study findings into opportunities for drug repositioning
Authors:
Preprint
Abstract
Drug development is a very costly and lengthy process, while repositioned or repurposed drugs could be brought into clinical practice within a shorter time-frame and at a much reduced cost. The past decade has observed a massive growth in the amount of data from genome-wide association studies (GWAS). The rich information contained in GWAS data has great potential to guide drug discovery or repositioning. Here we provide an overview of different computational approaches which employ GWAS data to guide drug repositioning. These methods include selection of top candidate genes from GWAS as drug targets, deducing drug candidates based on drug-drug and disease-disease similarity, searching for reversed expression profiles between drugs and diseases, pathway-based methods as well as repositioning based on analysis of biological networks. Each method is illustrated with examples, and their respective strengths and limitations are discussed. Finally we discussed several areas for future research.Keywords
All Related Versions
This publication has 98 references indexed in Scilit:
- Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing2018
- Network-Based Drug Repositioning: Approaches, Resources, and Research Directions2018
- Strategies for Pathway Analysis Using GWAS and WGS DataCurrent Protocols in Human Genetics, 2018
- Differential associations of depression‐related phenotypes with cardiometabolic risks: Polygenic analyses and exploring shared genetic variants and pathwaysDepression and Anxiety, 2018
- The Post-GWAS Era: From Association to FunctionThe American Journal of Human Genetics, 2018
- A tutorial on conducting genome‐wide association studies: Quality control and statistical analysisInternational Journal of Methods in Psychiatric Research, 2018
- Prospects of Fine-Mapping Trait-Associated Genomic Regions by Using Summary Statistics from Genome-wide Association StudiesThe American Journal of Human Genetics, 2017
- 10 Years of GWAS Discovery: Biology, Function, and TranslationThe American Journal of Human Genetics, 2017
- Mining drug–disease relationships as a complement to medical genetics‐based drug repositioning: Where a recommendation system meets genome‐wide association studiesClinical Pharmacology & Therapeutics, 2015
- Beyond GWASs: Illuminating the Dark Road from Association to FunctionThe American Journal of Human Genetics, 2013